SNYR Stock Overview
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom.
Synergy CHC Competitors
Price History & Performance
|Historical stock prices|
|Current Share Price||US$0.0055|
|52 Week High||US$0.17|
|52 Week Low||US$0.0001|
|1 Month Change||0%|
|3 Month Change||n/a|
|1 Year Change||-93.88%|
|3 Year Change||-97.66%|
|5 Year Change||-98.55%|
|Change since IPO||-99.73%|
Recent News & Updates
|SNYR||US Personal Products||US Market|
Return vs Industry: SNYR underperformed the US Personal Products industry which returned -18.1% over the past year.
Return vs Market: SNYR underperformed the US Market which returned -9.6% over the past year.
|SNYR Average Weekly Movement||n/a|
|Personal Products Industry Average Movement||10.6%|
|Market Average Movement||7.6%|
|10% most volatile stocks in US Market||16.8%|
|10% least volatile stocks in US Market||3.1%|
Stable Share Price: Insufficient data to determine SNYR's volatility over the past 3 months.
Volatility Over Time: Insufficient data to determine SNYR's volatility change over the past year.
About the Company
Synergy CHC Corp. provides consumer health care, beauty, and lifestyle products in the United States, Canada, and the United Kingdom. It offers brain health nutritional supplements under the FOCUSfactor brand name; lifestyle products and accessories, including tea, shakes, lollipops, supplements, apparel, and exercise accessories under the Flat Tummy brand name; anti-aging skincare products, such as serums and creams for exfoliating, skin repair, and rehydration, as well as hand soaps and hand sanitizers under the Hand MD brand name. The company sells its products through retailers and television advertising campaigns, as well as skincare products through online.
Synergy CHC Fundamentals Summary
|SNYR fundamental statistics|
Is SNYR overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|SNYR income statement (TTM)|
|Cost of Revenue||US$13.54m|
Last Reported Earnings
Sep 30, 2021
Next Earnings Date
|Earnings per share (EPS)||0.044|
|Net Profit Margin||8.49%|
How did SNYR perform over the long term?See historical performance and comparison
Is SNYR undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score 4/6
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Below Fair Value
Significantly Below Fair Value
Key Valuation Metric
Which metric is best to use when looking at relative valuation for SNYR?
Other financial metrics that can be useful for relative valuation.
|What is SNYR's n/a Ratio?|
Price to Earnings Ratio vs Peers
How does SNYR's PE Ratio compare to its peers?
|SNYR PE Ratio vs Peers|
|Company||PE||Estimated Growth||Market Cap|
PMPG Premier Products Group
INBP Integrated BioPharma
SNYR Synergy CHC
Price-To-Earnings vs Peers: SNYR is good value based on its Price-To-Earnings Ratio (0.1x) compared to the peer average (6.5x).
Price to Earnings Ratio vs Industry
How does SNYR's PE Ratio compare vs other companies in the US Personal Products Industry?
Price-To-Earnings vs Industry: SNYR is good value based on its Price-To-Earnings Ratio (0.1x) compared to the US Personal Products industry average (20.1x)
Price to Earnings Ratio vs Fair Ratio
What is SNYR's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
|Current PE Ratio||0.1x|
|Fair PE Ratio||n/a|
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate SNYR's Price-To-Earnings Fair Ratio for valuation analysis.
Share Price vs Fair Value
What is the Fair Price of SNYR when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: SNYR ($0.01) is trading below our estimate of fair value ($0.19)
Significantly Below Fair Value: SNYR is trading below fair value by more than 20%.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Analyst Forecast: Insufficient data to show price forecast.
Discover undervalued companies
How is Synergy CHC forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Future Growth Score0/6
Future Growth Score 0/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted Household industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Synergy CHC has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Discover growth companies
- Examine whether Synergy CHC is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- While we do not consider unaudited financials to be a reliable enough to include in our analysis, you can access them on the OTC Markets Website. If you are looking for more of a qualitative research into the company, you can access Synergy CHC's filings and announcements here.
How has Synergy CHC performed over the past 5 years?
Past Performance Score2/6
Past Performance Score 2/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: SNYR has a high level of non-cash earnings.
Growing Profit Margin: SNYR became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: SNYR has become profitable over the past 5 years, growing earnings by -3.6% per year.
Accelerating Growth: SNYR has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: SNYR has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (4.3%).
Return on Equity
High ROE: Whilst SNYR's Return on Equity (403.3%) is outstanding, this metric is skewed due to their high level of debt.
Discover strong past performing companies
How is Synergy CHC's financial position?
Financial Health Score4/6
Financial Health Score 4/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: SNYR's short term assets ($19.5M) exceed its short term liabilities ($19.2M).
Long Term Liabilities: SNYR's short term assets ($19.5M) exceed its long term liabilities ($944.6K).
Debt to Equity History and Analysis
Debt Level: SNYR's net debt to equity ratio (788.8%) is considered high.
Reducing Debt: SNYR's debt to equity ratio has increased from 69.6% to 833.3% over the past 5 years.
Debt Coverage: SNYR's debt is well covered by operating cash flow (22.8%).
Interest Coverage: SNYR's interest payments on its debt are well covered by EBIT (4x coverage).
Discover healthy companies
What is Synergy CHC current dividend yield, its reliability and sustainability?
Dividend Score 0/6
Cash Flow Coverage
Dividend Yield vs Market
Notable Dividend: Unable to evaluate SNYR's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate SNYR's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if SNYR's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if SNYR's dividend payments have been increasing.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as SNYR has not reported any payouts.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Jack Ross (56 yo)
Mr. Jack Ross has been the Chairman and Chief Executive Officer at Synergy CHC Corp. since October 27, 2014. He served as the Chief Financial Officer at Synergy CHC Corp. since August 17, 2018 until July 2...
CEO Compensation Analysis
Compensation vs Market: Insufficient data to establish whether Jack's total compensation is reasonable compared to companies of similar size in the US market.
Compensation vs Earnings: Jack's compensation has been consistent with company performance over the past year.
Experienced Management: SNYR's management team is considered experienced (4.6 years average tenure).
Experienced Board: SNYR's board of directors are considered experienced (7.7 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Synergy CHC Corp.'s employee growth, exchange listings and data sources
- Name: Synergy CHC Corp.
- Ticker: SNYR
- Exchange: OTCPK
- Founded: 2010
- Industry: Personal Products
- Sector: Household
- Implied Market Cap: US$494.389k
- Shares outstanding: 89.89m
- Website: https://synergychc.com
Number of Employees
- Synergy CHC Corp.
- 865 Spring Street
- United States
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/08/16 00:00|
|End of Day Share Price||2022/06/06 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.